Search research articles
Contact Us
Filters
Showing results (11-20 of 78) with videos related to
Page
of 8
Sort By:
Biological Psychiatry
|
February 21, 2024
Accelerated Theta Burst Stimulation: Safety, Efficacy, and Future Advancements
Eleanor Cole, Sean J O'Sullivan, Martin Tik, et al.
Journal of Neurophysiology
|
April 25, 2019
Case Studies in Neuroscience: The electrophysiology of a human obsession in nucleus accumbens
Kai J Miller, Thomas Prieto, Nolan R Williams, et al.
JAMA Psychiatry
|
May 2, 2019
Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect
Boris D Heifets, Nolan R Williams, Brandon S Bentzley, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 5, 2024
Should rTMS be considered a first-line treatment for major depressive episodes in adults?
Sean J O'Sullivan, Derrick M Buchanan, Jean-Marie V Batail, et al.
The American Journal of Psychiatry
|
November 2, 2023
An Avenue for Optimization of Theta Burst Stimulation Protocols? Comments on the FOUR-D Randomized Noninferiority Clinical Trial
Jean-Marie V Batail, Michael T Feyder, Brandon S Bentzley, et al.
Annals of Translational Medicine
|
May 9, 2017
It takes time to tune
Brandon S Bentzley, Jaspreet Pannu, Bashar W Badran, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 15, 2023
Targeted neurostimulation reverses a spatiotemporal biomarker of treatment-resistant depression
Anish Mitra, Marcus E Raichle, Andrew D Geoly, et al.
Brain Stimulation
|
July 12, 2025
Trigeminal nerve stimulation as an active control condition in TMS clinical trials: Evidence from heart-brain coupling and clinical outcomes
Martijn Arns, Nolan R Williams, Jonathan Downar, et al.
Brain Stimulation
|
April 10, 2025
Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression
Andrew D Geoly, Katy H Stimpson, Flint M Espil, et al.
The American Journal of Psychiatry
|
May 2, 2019
Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and Kaplin
Boris D Heifets, Nolan R Williams, Christine Blasey, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 78) with videos related to
Sort By:
Page
of 8
Biological Psychiatry
|
February 21, 2024
Accelerated Theta Burst Stimulation: Safety, Efficacy, and Future Advancements
Eleanor Cole, Sean J O'Sullivan, Martin Tik, et al.
Journal of Neurophysiology
|
April 25, 2019
Case Studies in Neuroscience: The electrophysiology of a human obsession in nucleus accumbens
Kai J Miller, Thomas Prieto, Nolan R Williams, et al.
JAMA Psychiatry
|
May 2, 2019
Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect
Boris D Heifets, Nolan R Williams, Brandon S Bentzley, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 5, 2024
Should rTMS be considered a first-line treatment for major depressive episodes in adults?
Sean J O'Sullivan, Derrick M Buchanan, Jean-Marie V Batail, et al.
The American Journal of Psychiatry
|
November 2, 2023
An Avenue for Optimization of Theta Burst Stimulation Protocols? Comments on the FOUR-D Randomized Noninferiority Clinical Trial
Jean-Marie V Batail, Michael T Feyder, Brandon S Bentzley, et al.
Annals of Translational Medicine
|
May 9, 2017
It takes time to tune
Brandon S Bentzley, Jaspreet Pannu, Bashar W Badran, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 15, 2023
Targeted neurostimulation reverses a spatiotemporal biomarker of treatment-resistant depression
Anish Mitra, Marcus E Raichle, Andrew D Geoly, et al.
Brain Stimulation
|
July 12, 2025
Trigeminal nerve stimulation as an active control condition in TMS clinical trials: Evidence from heart-brain coupling and clinical outcomes
Martijn Arns, Nolan R Williams, Jonathan Downar, et al.
Brain Stimulation
|
April 10, 2025
Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression
Andrew D Geoly, Katy H Stimpson, Flint M Espil, et al.
The American Journal of Psychiatry
|
May 2, 2019
Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and Kaplin
Boris D Heifets, Nolan R Williams, Christine Blasey, et al.
Page
of 8